LAGOS, NIGERIA
A months-long investigation by Ozempic.ng reveals that Novo Nordisk's Ozempic has never been registered with NAFDAC. Every pen sold in Nigeria is unverified, unregulated, and potentially dangerous.
0
NAFDAC Registrations
0+
Unverified Sellers
Price Markup
0
Safe Alternatives
Our team searched the NAFDAC Green Book — the official database of approved drugs in Nigeria. Ozempic (semaglutide injection by Novo Nordisk) returns zero results. It has never been submitted for registration.
Instagram and WhatsApp sellers offer "Ozempic pens" at inflated prices from unverified sellers. Investigation reveals these are repackaged generics or outright counterfeits with no cold-chain integrity, sold at extreme markups.
Compounded semaglutide — the same active ingredient as Ozempic — is available through licensed pharmacies at a fraction of the price. No brand-name premium, same clinical results.
Answer 5 questions about your seller
Your seller displays multiple red flags consistent with scam Ozempic operations. We strongly recommend discontinuing contact and exploring verified alternatives.
EXPLORE SAFE ALTERNATIVESYour seller shows fewer warning signs, but remember: Ozempic is NOT registered in Nigeria. Any pen sold here is unverified by NAFDAC regardless of seller behaviour.
LEARN ABOUT VERIFIED OPTIONSNovo Nordisk does not supply Ozempic to Nigeria. There is no authorized import channel.
Search the NAFDAC Green Book yourself. Ozempic has zero registrations. Any "number" is fabricated.
Without NAFDAC oversight, there is no verified cold-chain. You cannot confirm storage temperature history.
High price does not equal authenticity. Scammers use premium pricing to create false credibility.
Confirmed via direct search of the official NAFDAC registered drugs database, February 2026.
Published in NEJM and Lancet: semaglutide produces clinically significant weight loss. The molecule works. The brand is the problem.
Licensed compounding pharmacies produce semaglutide at regulated standards, at a fraction of the "Ozempic" street price.
Dual GIP/GLP-1 agonist tirzepatide achieves significant weight loss in published clinical research. Available through verified providers.
Every share could save someone from a fake Ozempic scam. Spread the word.
Correct. Ozempic (brand name semaglutide by Novo Nordisk) is not registered in the NAFDAC Green Book, which means it has never been officially approved for sale in Nigeria. Novo Nordisk has not applied for Nigerian registration. Any pen labelled "Ozempic" in Nigeria entered the country through unregulated channels with no guarantee of authenticity, proper storage, or correct dosing.
Our investigation indicates that "Ozempic" pens sold in Nigeria fall into three categories: (1) expired or damaged pens diverted from other markets, (2) cheap generic semaglutide repackaged in Ozempic-style boxes, or (3) outright counterfeits containing unknown substances. Without NAFDAC verification, there is no way to confirm what you are injecting.
Yes. Semaglutide is a well-studied molecule approved by the FDA, EMA, and other regulatory agencies worldwide. It is the active ingredient in both Ozempic and Wegovy. The problem in Nigeria is not the molecule but the unverified source. Compounded semaglutide from licensed pharmacies provides the same active ingredient with proper quality controls. Always consult a doctor before starting any GLP-1 therapy.
Ozempic is a brand name manufactured by Novo Nordisk in a pre-filled pen. Compounded semaglutide is the same active molecule prepared by licensed compounding pharmacies, typically in vial form. Both contain semaglutide. The difference is branding and delivery device, not the medicine itself. Compounded versions cost significantly less because there is no brand-name premium.
Start by consulting a licensed physician. Verified providers of compounded semaglutide and tirzepatide exist in Nigeria and operate with proper quality controls. Visit semaglutide.ng for information on legitimate options. Never purchase injectable medications from unverified social media sellers.